Literature DB >> 21174631

High prevalence of HIV type 1 subtype B' among heterosexuals in Western Hubei, Central China: bridging the epidemic into the general population.

Yue Li1, Yutaka Takebe, Jixian Yang, Wei Zhang, Rongge Yang.   

Abstract

A molecular epidemiological investigation (n = 62) conducted in western Hubei, Central China, revealed that HIV-1 subtype B' (Thailand variant of subtype B) predominated not only among former plasma donors (FPDs) (29/29, 100%) but also among heterosexuals (27/31, 87%), suggesting that subtype B' appears to bridge the spread from FPDs in the general population in this particular area in Central China.

Entities:  

Mesh:

Year:  2011        PMID: 21174631     DOI: 10.1089/aid.2010.0344

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  4 in total

1.  Researchers should use more data, not just the HIV sequence compendium, for epidemiology and other HIV research.

Authors:  Yanpeng Li; Yan Wang; Binlian Sun; Rongge Yang
Journal:  AIDS Res Hum Retroviruses       Date:  2014-08-14       Impact factor: 2.205

2.  A comprehensive mapping of HIV-1 genotypes in various risk groups and regions across China based on a nationwide molecular epidemiologic survey.

Authors:  Xiang He; Hui Xing; Yuhua Ruan; Kunxue Hong; Chunlin Cheng; Yuanyuan Hu; Ruolei Xin; Jing Wei; Yi Feng; Jenny H Hsi; Yutaka Takebe; Yiming Shao
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

Review 3.  Geographic Distribution and Temporal Trends of HIV-1 Subtypes through Heterosexual Transmission in China: A Systematic Review and Meta-Analysis.

Authors:  Peipei Xiao; Jianjun Li; Gengfeng Fu; Ying Zhou; Xiping Huan; Haitao Yang
Journal:  Int J Environ Res Public Health       Date:  2017-07-24       Impact factor: 3.390

4.  HIV-1 genotype diversity and distribution characteristics among heterosexually transmitted population in Jiangsu province, China.

Authors:  Peipei Xiao; Ying Zhou; Jing Lu; Li Yan; Xiaoqin Xu; Haiyang Hu; Jianjun Li; Ping Ding; Tao Qiu; Gengfeng Fu; Xiping Huan; Haitao Yang
Journal:  Virol J       Date:  2019-04-25       Impact factor: 4.099

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.